Corista, originally named after the Italian word ‘tuono corista’, is a tuning instrument used in orchestras and with choir members to keep musical pitch and consistency. Our founders have a passion for music and instrumentation, and with their backgrounds in healthcare and radiology, the name Corista seemed fitting as it marries the goals of quality and consistency in pathology labs and across the field of pathology.
Our founders, Elizabeth and Richard Wingard, had the foresight to bring harmony to pathology labs by building their advanced digital pathology image management system. Providing pathologists, data scientists, and researchers with a central platform, DP3 enables efficient management of digital image data, optimized analysis and annotations, and enhanced peer-to-peer collaboration that overcomes geographic barriers and connectivity challenges.
Meet the Team Powering Our Image Management Platform
Mr. Wingard is a seasoned healthcare technology executive with more than 25 years of experience driving innovation in medical imaging, telecommunications, and digital health. Over the course of his career, he has held senior leadership roles at organizations including Access Radiology Corporation, Tel-Care Inc., Multimedia Medical Systems, Vidimedix Corporation, Sprint, and AT&T, where he consistently pioneered breakthrough solutions that reshaped how healthcare is delivered and experienced.
In the 1990s, Mr. Wingard played a key role in advancing digital healthcare solutions. At Access Radiology, he led the development and commercialization of one of the first digital radiology SaaS platforms in the U.S., contributing to the company’s eventual acquisition. At Tel-Care, he introduced the first digital TV-based patient education and entertainment system, enabling hospitals to improve patient engagement while generating new revenue streams. His work at Multimedia Medical Systems, in collaboration with the University of Virginia, helped bring to market an FDA-approved radioactive seed imaging system for prostate cancer treatment that remains widely used today. Additionally, at Nomos, he contributed to the development of inverse planning software, a breakthrough in radiation therapy that is now foundational in cancer treatment worldwide.
In the early 2000s, Mr. Wingard continued to lead innovation in telemedicine and remote care. At Vidimedix, he developed advanced telemedicine systems integrating remote diagnostics and treatment capabilities, earning global recognition. Through Image Labs, and in collaboration with Brigham & Women’s Hospital, he helped pioneer telecardiology solutions that enabled real-time remote cardiac procedure support—technology that has since become standard practice.
During his time as CEO at EuclidIQ, Mr. Wingard led the development of cutting-edge video processing and compression technologies, with over 52 patents granted or pending. Under his leadership, EuclidIQ enabled high-definition video streaming to mobile devices in bandwidth-constrained environments and supported advancements in the global mobile advertising industry by improving ad delivery and engagement.
Mr. Wingard holds a Bachelor of Arts degree in Psychology from the University of North Carolina at Charlotte. His career reflects a consistent pattern of innovation, commercialization, and industry impact, culminating in the founding of Corista and continued leadership in advancing digital pathology and healthcare technology solutions.
David C. Wilbur, MDChief Scientific Officer & Pathologist
Chief Scientific Officer & Pathologist David C. Wilbur, MD, is leading the medical efforts for Corista’s artificial intelligence studies. Dr. Wilbur is focused on using technology to improve physician workflows, productivity, and accuracy.
Prior to retirement from clinical practice, Dr. Wilbur was Director of the Cytopathology Unit at Massachusetts General Hospital and led the Pathology Department’s initiative in clinical digital pathology. Dr. Wilbur remains a Professor of Pathology Emeritus at Harvard Medical School.
A graduate of Johns Hopkins, Dr. Wilbur earned his medical degree at the University of Rochester. He has authored over 200 scientific papers and is the co-editor of the 3rd and 4th editions of the popular textbook Comprehensive Cytopathology, as well as several other pathology texts. He has received numerous awards for his work in pathology, including The College of American Pathologists President’s Honors, Lifetime Achievement, and Distinguished Service awards. He is a past president of the American Society of Cytopathology and, in 2010, received that society’s highest honor – the Papanicolaou Award.
Dr. Barrett brings over three decades of experience in translational research to Corista as Chief Life Sciences Officer, leading biomarker development strategies using digital pathology. Prior to joining Corista, Dr. Barrett was Vice President of Translational Medicine and Oncology Biomarker Development in Oncology Research and Development at AstraZeneca. His responsibilities included developing and executing biomarker strategies and translational sciences efforts to support drug development. Dr. Barrett also served as the Global Head of Oncology Biomarkers and Imaging at Novartis Oncology Translational Medicine. He was the founding Director of the NCI Center for Cancer Research (CCR), which is part of the NCI Intramural Center for Translational Medicine and Novel Technologies.
Ms. Wingard founded Corista with the goal of delivering a platform for physicians that would dramatically improve the delivery of pathology. With more than 25 years of experience in business development, sales, and marketing, Ms. Wingard has specialized in the introduction of innovative technologies for emerging markets. In previous positions, she was the key driver of growth for companies delivering technologies to Fortune 1000 companies in several industries, including healthcare, telecommunications, banking, and business process management. Ms. Wingard has built revenue streams of over $1B for the business ventures she’s led.
Prior to launching Corista, Ms. Wingard held senior executive positions in sales and business development for a wide range of technology-driven companies, including Op40, Vicorp, IBJ Schroder, Sprint, and AT&T.
Ms. Wingard holds a BA and an MA from the University of Southern Mississippi.
Wayne ButlerChief Commercial Officer & Executive Vice President
Wayne ButlerChief Commercial Officer & Executive Vice PresidentFollow me on LinkedIn
Wayne Butler brings more than 25 years of leadership in Life Sciences, Clinical, and CRO markets to Corista. As Chief Commercial Officer, he has guided the company’s shift to continuous customer engagement, expanded global partnerships, and built a multimillion-dollar growth pipeline.
Before joining Corista, Wayne held senior roles at Proscia, Leica Biosystems (Danaher), Sparta Systems, and Xybion. His experience includes driving enterprise agreements with industry leaders such as Novartis, Pfizer, and Eli Lilly.
Wayne is known for developing strong partner ecosystems, leading large-scale commercial transformations, and consistently exceeding growth targets. He is a graduate of Hobart and William Smith Colleges and has served in multiple board-level leadership initiatives.
Conner WingardChief Technical Officer & Executive Vice President
Conner WingardChief Technical Officer & Executive Vice PresidentFollow me on LinkedIn
Conner Wingard has been with Corista since 2008, when he helped develop the first prototypes of what would become the DP3 platform. Over the years, he’s served as a key contributor, technical lead, and architect before moving into leadership as the company grew.
With 15 years of software engineering experience, Conner is Corista’s resident technologist and problem solver. He has a passion for product design and development, building strong teams, and helping customers successfully adopt digital pathology solutions.
He holds a BA in Electronic Game Programming from Champlain College.
Carolyn SykesVice President of Finance & Operations
Carolyn SykesVice President of Finance & Operations
Carolyn Sykes is a strategic finance leader who designs scalable financial systems that align operations, cash flow, and reporting to support sustainable growth. Specializing in post-acquisition integration, fundraise readiness, and finance function buildouts, she partners closely with founders and leadership teams.
Shape the Future of Pathology With Us
Corista is expanding, and we’re excited to welcome new talent to our team, where some of the top minds from healthcare and life sciences are driving innovations in digital pathology. If you're passionate about making a difference and eager to contribute, we’d love for you to join us.
